MedTrace Logo

Cell-free Circulating DNA in Primary Cutaneous Lymphomas

NCT02883517 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 35

Last updated 2022-05-13

No results posted yet for this study

Summary

To evaluate the possibility of detecting cell-free circulating tumoral DNA in potentially aggressive primary cutaneous lymphomas, the investigator opted to search a representative tumor sample mutation in the blood of these patients, by digital PCR. Patients with mycosis fungoides, primary cutaneous T-cell lymphoma helper follicular phenotype and primary cutaneous diffuse large B-cell lymphoma, leg-type will be included and 4 blood samples will be collected during 12 months.

Conditions

  • Mycosis Fungoides
  • Lymphoma, Large B-cell, Diffuse

Interventions

GENETIC

Cytogenetic and molecular studies

Detect cell-free circulating tumoral DNA in a blood sample, with correlations with clinical characteristics and metastatic outcome.

Sponsors & Collaborators

  • University Hospital, Bordeaux

    lead OTHER

Principal Investigators

  • Anne PHAM-LEDARD, MD · University Hospital, Bordeaux

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-11-22
Primary Completion
2019-12-16
Completion
2019-12-16

Countries

  • France

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02883517 on ClinicalTrials.gov